A detailed history of Ferguson Wellman Capital Management, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 795,536 shares of MRK stock, worth $80.4 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
795,536
Previous 720,286 10.45%
Holding current value
$80.4 Million
Previous $81.8 Million 10.45%
% of portfolio
1.81%
Previous 1.79%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$111.15 - $128.97 $8.36 Million - $9.7 Million
75,250 Added 10.45%
795,536 $90.3 Million
Q3 2024

Oct 18, 2024

BUY
$111.15 - $128.97 $28 Million - $32.5 Million
251,942 Added 53.79%
720,286 $81.8 Million
Q2 2024

Jul 16, 2024

BUY
$123.8 - $132.96 $791,824 - $850,412
6,396 Added 1.38%
468,344 $58 Million
Q1 2024

Apr 09, 2024

SELL
$113.24 - $131.95 $131,018 - $152,666
-1,157 Reduced 0.25%
461,948 $61 Million
Q4 2023

Jan 11, 2024

BUY
$100.18 - $109.02 $5.48 Million - $5.96 Million
54,684 Added 13.39%
463,105 $50.5 Million
Q3 2023

Oct 12, 2023

SELL
$102.95 - $114.33 $264,684 - $293,942
-2,571 Reduced 0.63%
408,421 $42 Million
Q2 2023

Jul 11, 2023

SELL
$108.61 - $118.38 $201,145 - $219,239
-1,852 Reduced 0.45%
410,992 $47.4 Million
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $126,822 - $141,507
1,232 Added 0.3%
412,844 $43.9 Million
Q4 2022

Jan 13, 2023

BUY
$87.44 - $112.11 $26 Million - $33.3 Million
296,926 Added 258.9%
411,612 $45.7 Million
Q3 2022

Oct 17, 2022

BUY
$84.53 - $94.96 $1.14 Million - $1.28 Million
13,520 Added 13.36%
114,686 $9.88 Million
Q2 2022

Jul 14, 2022

SELL
$83.49 - $94.64 $228,011 - $258,461
-2,731 Reduced 2.63%
101,166 $9.22 Million
Q1 2022

Apr 14, 2022

SELL
$73.51 - $82.4 $335,132 - $375,661
-4,559 Reduced 4.2%
103,897 $8.53 Million
Q4 2021

Jan 10, 2022

SELL
$72.28 - $90.54 $1 Million - $1.25 Million
-13,844 Reduced 11.32%
108,456 $8.31 Million
Q3 2021

Oct 22, 2021

SELL
$71.68 - $78.83 $1.31 Million - $1.44 Million
-18,254 Reduced 12.99%
122,300 $9.19 Million
Q2 2021

Jul 12, 2021

SELL
$70.31 - $77.77 $1.3 Million - $1.44 Million
-18,494 Reduced 11.63%
140,554 $10.9 Million
Q1 2021

Apr 26, 2021

SELL
$68.86 - $81.11 $48.2 Million - $56.7 Million
-699,541 Reduced 81.48%
159,048 $12.3 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $88,994 - $98,766
-1,240 Reduced 0.14%
858,589 $70.2 Million
Q3 2020

Oct 13, 2020

BUY
$73.18 - $82.95 $324,187 - $367,468
4,430 Added 0.52%
859,829 $71.3 Million
Q2 2020

Aug 04, 2020

SELL
$70.42 - $80.13 $3.66 Million - $4.17 Million
-52,008 Reduced 5.73%
855,399 $66.1 Million
Q1 2020

Apr 21, 2020

SELL
$63.36 - $87.82 $280,241 - $388,427
-4,423 Reduced 0.49%
907,407 $69.8 Million
Q4 2019

Jan 24, 2020

BUY
$77.58 - $87.54 $378,823 - $427,457
4,883 Added 0.54%
911,830 $82.9 Million
Q3 2019

Oct 15, 2019

SELL
$76.08 - $82.93 $491,933 - $536,225
-6,466 Reduced 0.71%
906,947 $76.3 Million
Q2 2019

Jul 16, 2019

SELL
$69.84 - $81.59 $19.1 Million - $22.3 Million
-273,352 Reduced 23.03%
913,413 $76.6 Million
Q1 2019

Apr 11, 2019

BUY
$69.58 - $79.36 $10.2 Million - $11.6 Million
145,895 Added 14.02%
1,186,765 $98.7 Million
Q4 2018

Jan 16, 2019

BUY
$65.24 - $75.71 $812,368 - $942,740
12,452 Added 1.21%
1,040,870 $75.9 Million
Q3 2018

Oct 25, 2018

BUY
$57.69 - $67.84 $714,029 - $839,655
12,377 Added 1.22%
1,028,418 $73 Million
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $768,702 - $903,145
15,123 Added 1.51%
1,016,041 $61.7 Million
Q1 2018

Apr 09, 2018

SELL
$50.96 - $59.23 $1.28 Million - $1.49 Million
-25,085 Reduced 2.44%
1,000,918 $54.5 Million
Q4 2017

Jan 24, 2018

SELL
$51.62 - $61.64 $11.2 Million - $13.4 Million
-217,435 Reduced 17.49%
1,026,003 $57.7 Million
Q3 2017

Oct 11, 2017

BUY
$58.67 - $63.13 $73 Million - $78.5 Million
1,243,438
1,243,438 $79.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.